Pathway Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
4,500
+1,100
+32% +$256K 0.14% 64
2026
Q1
$826K Sell
3,400
-1,573
-32% -$366K 0.1% 66
2025
Q4
$1.02M Hold
4,973
0.13% 65
2025
Q3
$922K Hold
4,973
0.12% 67
2025
Q2
$760K Sell
4,973
-66
-1% -$10.1K 0.11% 68
2025
Q1
$836K Sell
5,039
-10
-0.2% -$1.56K 0.15% 66
2024
Q4
$730K Buy
5,049
+74
+1% +$11.5K 0.17% 69
2024
Q3
$806K Sell
4,975
-561
-10% -$89.4K 0.21% 57
2024
Q2
$809K Hold
5,536
0.22% 57
2024
Q1
$876K Buy
5,536
+98
+2% +$15.6K 0.24% 51
2023
Q4
$852K Buy
5,438
+226
+4% +$34.7K 0.25% 49
2023
Q3
$812K Sell
5,212
-111
-2% -$18.3K 0.28% 44
2023
Q2
$881K Buy
5,323
+2
+0% +$323 0.29% 40
2023
Q1
$825K Hold
5,321
0.28% 40
2022
Q4
$940K Sell
5,321
-1,208
-19% -$209K 0.29% 39
2022
Q3
$1.07M Buy
6,529
+886
+16% +$150K 0.37% 36
2022
Q2
$1M Buy
5,643
+55
+1% +$9.8K 0.42% 38
2022
Q1
$990K Sell
5,588
-84
-1% -$14.3K 0.37% 39
2021
Q4
$977K Buy
+5,672
New +$929K 0.35% 38
2021
Q1
$950K Hold
5,555
0.38% 36
2020
Q4
$880K Sell
5,555
-13
-0.2% -$1.92K 0.37% 37
2020
Q3
$820K Sell
5,568
-247
-4% -$36.5K 0.32% 34
2020
Q2
$818K Sell
5,815
-1,352
-19% -$197K 0.25% 35
2020
Q1
$962K Buy
7,167
+1,427
+25% +$202K 0.32% 27
2019
Q4
$857K Buy
5,740
+3,131
+120% +$425K 0.24% 41
2019
Q3
$347K Sell
2,609
-15
-0.6% -$1.98K 0.1% 66
2019
Q2
$366K Sell
2,624
-326
-11% -$45.1K 0.11% 64
2019
Q1
$412K Buy
2,950
+458
+18% +$61.3K 0.13% 59
2018
Q4
$322K Hold
2,492
0.18% 67
2018
Q3
$324K Sell
2,492
-11,029
-82% -$1.47M 0.18% 68
2018
Q2
$1.64M Hold
13,521
0.96% 19
2018
Q1
$1.73M Sell
13,521
-26
-0.2% -$3.51K 1.01% 18
2017
Q4
$1.89M Buy
+13,547
New +$1.89M 1.09% 17

Other funds holding JNJ

Pathway Financial Advisors's JNJ Position: Q2 2026 in Review

Pathway Financial Advisors increased its Johnson & Johnson (JNJ) stake by 32% in Q2 2026, buying an estimated $256K and bringing the position to 4,500 shares worth $1.18M. The position accounts for 0.14% of the portfolio, ranked #64.

Pathway Financial Advisors first reported a position in JNJ in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.89M in Q4 2017. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Pathway Financial Advisors held 4,500 shares of Johnson & Johnson worth $1.18M as of Q2 2026.
  • Pathway Financial Advisors bought 1,100 Johnson & Johnson shares in Q2 2026, an estimated $256K.
  • Johnson & Johnson made up 0.14% of Pathway Financial Advisors's portfolio in Q2 2026, its #64 holding.
  • Pathway Financial Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 33 quarters since.
  • Pathway Financial Advisors's Johnson & Johnson position peaked at $1.89M in Q4 2017.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Pathway Financial Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.